Patients and doctors will soon have a new method for monitoring cardiac health, thanks to advancements in technology developed by Medicomp. TelePatch™ is the latest breakthrough in the world of ECG patches. This innovative product is a 3-in-1 monitoring system that works as a short- and long-term Holter, a wireless event monitor, and a mobile cardiac telemetry unit, which is the first of its kind with most cardiac monitoring providers only offering just one or two monitoring services in one device. Physicians will be able to have customizable reports to be fully informed in a way that best fits each individual’s need. Our reports offer a combination of multiple visual formats, allows the prioritizing and reordering of dashboards, and presents reports designed by physicians, for physicians.
In addition to the multiple monitoring services, the TelePatch™ will be the first patch monitor that is water resistant, which means that patients actively using this monitor will not have to remove it while showering. In terms of comfort and durability, the monitor will stay on for up to seven days. Our research team found that one of the biggest frustrations that we hear from patients is that competitors’ patch monitors do not stick well and continually falls off. The TelePatch™ is designed to stay on for up to seven days and not cause irritation on most skin types.
Furthermore, the monitoring system TelePatch™ has an industry-leading battery life, thus allowing our patients to be able to monitor for longer periods of time. Not only this, but the device uses our patented Diogenes algorithm. Medicomp is the only company offering ambulatory cardiac monitoring technology that provides beat-for-beat rate, rhythm, morphology, and P-Wave analysis on every monitor. Unquestionably, TelePatch™ is the future of remote cardiac monitoring.
Read more about the latest in wearable cardiac monitors and other technological breakthroughs, such as TelePatch™, in our latest blogs, or contact one of Medicomp’s dedicated professionals at (800) 23-HEART (234-3278). After years of testing and development, Medicomp is proud to announce that the TelePatch™ is set to the launch in the first quarter of 2016.